Investment Rating - The investment rating for the company is "Buy" [8] Core Views - The company's Q1 2025 report indicates a rebound in net interest margin and a stable performance in non-performing loans, supported by a reduction in impairment losses [1][2][3] Summary by Relevant Sections Performance Overview - In Q1 2025, the company's revenue decreased by 7.1% year-on-year, a decline of 13.3 percentage points compared to 2024 annual results. The net profit attributable to the parent company increased by 0.6% year-on-year, a slight decline of 0.3 percentage points from 2024 annual results. The non-performing loan ratio remained stable at 1.38%, while the provision coverage ratio decreased by 7 percentage points to 171% [2][5] Profit Support from Provisions - The Q1 2025 revenue decline of 7.1% year-on-year was driven by a combination of improved net interest margin, negative impacts from non-interest income, and a significant reduction in impairment losses. The net interest margin for Q1 2025 was 1.61%, an increase of 30 basis points from Q4 2024, with a year-on-year decline narrowing by 35 basis points. Non-interest income saw a year-on-year decline of 24.9%, while impairment losses decreased by 20.4% compared to the previous year [3][4] Interest Margin Recovery - The net interest margin for Q1 2025 was 1.61%, reflecting a 30 basis point increase from Q4 2024. This improvement was attributed to a rise in asset yield by 13 basis points to 3.63% and a decrease in liability cost by 19 basis points to 1.94% [4] Non-Performing Loan Performance - The non-performing loan ratio remained stable at 1.38% at the end of Q1 2025. The generation rate of non-performing loans decreased by 15 basis points compared to the first half of 2024, indicating a need to monitor future pressures on new non-performing loans [5] Earnings Forecast and Valuation - The forecast for net profit attributable to the parent company is expected to grow by 0.60% in 2025, 0.95% in 2026, and 1.43% in 2027. The target price is set at 3.95 CNY per share, corresponding to a price-to-book ratio of 0.60 for 2025, indicating a potential upside of 32% from the current price of 2.99 CNY per share [6]

Core Viewpoints - The company's revenue growth has rebounded, with a 7.41% increase in Q1 2025, up 10.63 percentage points from the full year of 2024, driven by stable scale, recovering interest margins, and significant growth in non-interest income [2] - The net interest margin has improved, with a net interest margin of 1.41% in Q1 2025, up 2 basis points from the full year of 2024, and up 3 basis points from Q1 2024 [2] - The asset quality indicators remain stable, with a slight decrease in the non-performing loan ratio to 1.46%, down 1 basis point from the end of Q4 2024 [2] Revenue and Profitability - Q1 2025 operating income, pre-provision operating profit (PPOP), and net profit attributable to shareholders grew by 7.41%, 9.98%, and -5.13% year-on-year, respectively [1] - The growth rates for PPOP and net profit have increased by 15.37 percentage points and 4.72 percentage points compared to the full year of 2024 [1] Non-Interest Income and Asset Growth - Non-interest income saw a significant year-on-year increase of 43.79% in Q1 2025, with a growth rate improvement of 42.7 percentage points compared to the full year of 2024 [2] - Total assets grew by 0.72% year-on-year in Q1 2025, with loan growth at 0.48%, both showing a decline in growth rates compared to the full year of 2024 [3] Investment Recommendations - The company shows signs of revenue growth recovery, improving interest margins, and stable asset quality indicators, suggesting potential for valuation recovery if macroeconomic policies continue to support economic recovery [3]